A two-component chemical and biological approach based on a Photoswitchable Tethered Ligand (PTL) and a modified ionotropic glutamate receptor (LiGluR) was recently developed. The PTL Maleimide-Azobenzene-Glutamate (MAG) takes advantage of the photochemistry of azobenzene, which changes its shape depending on the irradiation wavelength used. When MAG covalently binds via its maleimide end to an engineered cysteine residue near the ligand binding domain of LiGluR, it allows for the precise control of channel gating, as light isomerizes the azobenzene and docks or removes the glutamate from the receptor binding site. The photochemical properties of MAG offer opportunity for shifting the activating wavelength from UV light (380 nm), which is scattered by tissue and therefore penetrates poorly. We have synthesized a red-shifted MAG (460 nm peak absorption) and used it on LiGluR in whole-cell patch clamp experiments in HEK293 cells. The red-shifted MAG functions as state-dependent tethered agonist, which can be activated with a broad spectrum of visible light and thermally relaxes to inactivity.View Large Image | View Hi-Res Image | Download PowerPoint Slide